MiMedx Group Investor Relations Material
Latest events
Q1 2025
MiMedx Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from MiMedx Group Inc
Access all reports
MiMedx Group Inc. is a biopharmaceutical company specializing in regenerative medicine. The company develops and markets advanced products derived from human placental tissue to support wound healing and tissue repair. MiMedx’s solutions are used in areas such as chronic wound care, surgical applications, and musculoskeletal conditions. The company is headquartered in Marietta, Georgia, and its shares are listed on the NASDAQ.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
MDXG
Country
🇺🇸 United States